[{"address1": "9000 Virginia Manor Road", "address2": "Suite 200", "city": "Beltsville", "state": "MD", "zip": "20705", "country": "United States", "phone": "240 399 4900", "website": "https://www.nextcure.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "NextCure, Inc., a clinical-stage biopharmaceutical company, engages in advancing medicines to treat cancer. The company's product candidate is the LNCB74, a B7-H4 targeted ADC to kill tumors. It also develops NC410, a fusion protein of LAIR-2, that is designed to block immune suppression mediated by LAIR-1; NC525, a novel LAIR-1 antibody that targets acute myeloid leukemia, blast cells, and leukemic stem cells; NC181 a humanized antibody targeting ApoE4 for the treatment of Alzheimer's disease; and NC605 an antibody that targets Siglec-15, as well as chronic bone diseases, such as osteoarthritis and non-union fractures. The company also develop SIM0505, a novel antibody-drug conjugate (ADC) targeting CDH6 (cadherin-6 or K-cadherin) for the treatment of solid tumors. NextCure, Inc. was incorporated in 2015 and is headquartered in Beltsville, Maryland.", "fullTimeEmployees": 43, "companyOfficers": [{"maxAge": 1, "name": "Mr. Michael S. Richman MSBA", "age": 63, "title": "Co-Founder, CEO, President & Director", "yearBorn": 1961, "fiscalYear": 2024, "totalPay": 852699, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Timothy  Mayer Ph.D.", "age": 59, "title": "Chief Operating Officer", "yearBorn": 1965, "fiscalYear": 2024, "totalPay": 619306, "exercisedValue": 0, "unexercisedValue": 12677}, {"maxAge": 1, "name": "Dr. Lieping  Chen M.D., Ph.D.", "age": 67, "title": "Co-Founder & Chairman of Scientific Advisory Board", "yearBorn": 1957, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Steven P. Cobourn CPA", "age": 60, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 313251, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin G. Shaw", "age": 49, "title": "Senior VP & General Counsel", "yearBorn": 1975, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Sourav  Kundu Ph.D.", "age": 63, "title": "Senior Vice President of Development & Manufacturing", "yearBorn": 1961, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sebastien  Maloveste Ph.D.", "title": "Senior Vice President of Business Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Udayan  Guha M.D., Ph.D.", "age": 52, "title": "Chief Medical Officer", "yearBorn": 1972, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 7, "compensationRisk": 8, "shareHolderRightsRisk": 6, "overallRisk": 7, "governanceEpochDate": 1761955200, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.63, "open": 13.67, "dayLow": 13.67, "dayHigh": 14.34, "regularMarketPreviousClose": 13.63, "regularMarketOpen": 13.67, "regularMarketDayLow": 13.67, "regularMarketDayHigh": 14.34, "payoutRatio": 0.0, "beta": 1.558, "forwardPE": -9.8531475, "volume": 21668, "regularMarketVolume": 21668, "averageVolume": 48282, "averageVolume10days": 63450, "averageDailyVolume10Day": 63450, "bid": 13.67, "ask": 14.17, "bidSize": 1, "askSize": 1, "marketCap": 47740444, "fiftyTwoWeekLow": 2.688, "fiftyTwoWeekHigh": 15.74, "allTimeHigh": 1308.0, "allTimeLow": 2.688, "fiftyDayAverage": 8.85422, "twoHundredDayAverage": 6.62618, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 14036692, "profitMargins": 0.0, "floatShares": 1911731, "sharesOutstanding": 3388250, "sharesShort": 19081, "sharesShortPriorMonth": 10909, "sharesShortPreviousMonthDate": 1760486400, "dateShortInterest": 1763078400, "sharesPercentSharesOut": 0.0056, "heldPercentInsiders": 0.20165001, "heldPercentInstitutions": 0.32849997, "shortRatio": 0.22, "shortPercentOfFloat": 0.0057, "impliedSharesOutstanding": 3388250, "bookValue": 8.836, "priceToBook": 1.5946128, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -58011000, "trailingEps": -23.81, "forwardEps": -1.43, "lastSplitFactor": "1:12", "lastSplitDate": 1752451200, "enterpriseToEbitda": -0.243, "52WeekChange": 0.012212634, "SandP52WeekChange": 0.1326145, "quoteType": "EQUITY", "currentPrice": 14.09, "targetHighPrice": 20.0, "targetLowPrice": 15.0, "targetMeanPrice": 17.66667, "targetMedianPrice": 18.0, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 3, "totalCash": 29110000, "totalCashPerShare": 10.863, "ebitda": -57820000, "totalDebt": 5388000, "quickRatio": 2.675, "currentRatio": 2.969, "debtToEquity": 22.786, "returnOnAssets": -0.58013, "returnOnEquity": -1.16913, "freeCashflow": -29165250, "operatingCashflow": -48944000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "NXTC", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": 3.37491, "regularMarketPrice": 14.09, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1764358525, "regularMarketTime": 1764352801, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1557408600000, "exchange": "NMS", "messageBoardId": "finmb_321460821", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": 0.07026326, "postMarketPrice": 14.0999, "postMarketChange": 0.009900093, "regularMarketChange": 0.46, "regularMarketDayRange": "13.67 - 14.34", "shortName": "NextCure, Inc.", "longName": "NextCure, Inc.", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 48282, "fiftyTwoWeekLowChange": 11.402, "fiftyTwoWeekLowChangePercent": 4.2418156, "fiftyTwoWeekRange": "2.688 - 15.74", "fiftyTwoWeekHighChange": -1.6499996, "fiftyTwoWeekHighChangePercent": -0.10482844, "fiftyTwoWeekChangePercent": 1.2212634, "earningsTimestampStart": 1753873140, "earningsTimestampEnd": 1754308800, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -23.81, "epsForward": -1.43, "epsCurrentYear": -14.29667, "priceEpsCurrentYear": -0.9855442, "fiftyDayAverageChange": 5.23578, "fiftyDayAverageChangePercent": 0.59133154, "twoHundredDayAverageChange": 7.46382, "twoHundredDayAverageChangePercent": 1.1264137, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "NextCure", "trailingPegRatio": null, "__fetch_time": "2025-11-29"}]